Jefferies Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-19,865
Closed -$1.69M 1205
2021
Q4
$1.69M Sell
19,865
-6,942
-26% -$591K 0.01% 468
2021
Q3
$2.57M Sell
26,807
-14,736
-35% -$1.41M 0.02% 353
2021
Q2
$4.04M Buy
41,543
+6,483
+18% +$631K 0.03% 304
2021
Q1
$3.41M Buy
35,060
+35,001
+59,324% +$3.4M 0.03% 284
2020
Q4
$5.66K Sell
59
-34,518
-100% -$3.31M ﹤0.01% 971
2020
Q3
$3.33M Buy
34,577
+27,327
+377% +$2.63M 0.04% 202
2020
Q2
$885 Sell
7,250
-27,796
-79% -$3.39K 0.01% 452
2020
Q1
$3.03M Sell
35,046
-16,233
-32% -$1.4M 0.03% 236
2019
Q4
$5.51M Sell
51,279
-93,066
-64% -$10M 0.04% 216
2019
Q3
$13M Buy
144,345
+74,173
+106% +$6.68M 0.1% 39
2019
Q2
$5.93M Buy
70,172
+67,615
+2,644% +$5.71M 0.04% 135
2019
Q1
$225K Sell
2,557
-53,689
-95% -$4.72M ﹤0.01% 1195
2018
Q4
$4.02M Buy
56,246
+3,123
+6% +$223K 0.03% 218
2018
Q3
$6.53M Sell
53,123
-17,755
-25% -$2.18M 0.04% 162
2018
Q2
$6.96M Buy
70,878
+65,878
+1,318% +$6.47M 0.04% 148
2018
Q1
$415K Sell
5,000
-1,868
-27% -$155K ﹤0.01% 980
2017
Q4
$533K Buy
6,868
+3,519
+105% +$273K ﹤0.01% 1036
2017
Q3
$205K Buy
+3,349
New +$205K ﹤0.01% 1341
2017
Q1
Sell
-9,216
Closed -$357K 1619
2016
Q4
$357K Sell
9,216
-4,494
-33% -$174K ﹤0.01% 932
2016
Q3
$694K Buy
13,710
+6,707
+96% +$340K ﹤0.01% 713
2016
Q2
$318K Buy
+7,003
New +$318K ﹤0.01% 850
2016
Q1
Hold
0
1458
2015
Q4
Hold
0
1436
2014
Q1
Sell
-12,396
Closed -$116K 1452
2013
Q4
$116K Buy
12,396
+12,200
+6,224% +$114K ﹤0.01% 1071
2013
Q3
$2K Sell
196
-312
-61% -$3.18K ﹤0.01% 1192
2013
Q2
$7K Buy
+508
New +$7K ﹤0.01% 1133